Akums Drugs & Pharmaceuticals Share Price
Start SIP in Akums Drugs & Pharmaceuticals
Start SIPAkums Drugs & Pharmaceuticals Performance
Day Range
- Low 852
- High 895
52 Week Range
- Low 725
- High 1,176
- Open Price891
- Previous Close889
- Volume143280
Akums Drugs & Pharmaceuticals Investment Rating
-
Master Rating:
-
Akums Drugs And Pharmaceuticals Ltd has an operating revenue of Rs. 6,588.03 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 4% needs improvement, ROE of 13% is good. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 24% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 126 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Jun 2023 |
|---|---|---|---|
| Oper Rev Qtr Cr | 317 | 298 | 316 |
| Operating Expenses Qtr Cr | 274 | 359 | 503 |
| Operating Profit Qtr Cr | 44 | -61 | -187 |
| Depreciation Qtr Cr | 9 | 9 | 7 |
| Interest Qtr Cr | 6 | 5 | 4 |
| Tax Qtr Cr | 12 | 9 | 11 |
| Net Profit Qtr Cr | 42 | -58 | -190 |
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹896.41
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹892.72
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
Akums Drugs & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 883.13 |
| Second Resistance | 911.02 |
| Third Resistance | 926.58 |
| RSI | 49.98 |
| MFI | 55.51 |
| MACD Single Line | 0.00 |
| MACD | 0.00 |
| Support | |
|---|---|
| First Support | 839.68 |
| Second Support | 824.12 |
| Third Supoort | 796.23 |
Akums Drugs & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 164,047 | 11,460,323 | 69.86 |
| Week | 222,119 | 11,685,681 | 52.61 |
| 1 Month | 494,527 | 22,055,900 | 44.6 |
| 6 Month | 382,458 | 18,094,087 | 47.31 |
Akums Drugs & Pharmaceuticals Result Highlights
Akums Drugs & Pharmaceuticals Synopsis
NSE-Medical-Products
Akums Drugs & Pharma is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1286.83 Cr. and Equity Capital is Rs. 28.61 Cr. for the Year ended 31/03/2023. Akums Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 19/04/2004 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U24239DL2004PLC125888 and registration number is 125888.| Market Cap | 13,984 |
| Sales | 616 |
| Shares in Float | 3.93 |
| No of funds | |
| Yield |
| Book Value | 40.81 |
| U/D Vol ratio | 0.3 |
| LTDebt / Equity | 7 |
| Alpha | 0.42 |
| Beta | 0.21 |
Akums Drugs & Pharmaceuticals Shareholding Pattern
| Owner Name |
|---|
Akums Drugs & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Sanjeev Jain | Managing Director |
| Mr. Sandeep Jain | Managing Director |
| Mr. Sanjay Sinha | Whole Time Director |
| Mr. Sunil Kumar Thakur | Non Exe. & Nominee Director |
| Ms. Matangi Gowrishankar | Independent Director |
| Mr. Kewal Kundanlal Handa | Independent Director |
| Mr. Nand Lal Kalra | Independent Director |
| Mr. Satwinder Singh | Independent Director |
Akums Drugs & Pharmaceuticals Forecast
Price Estimates
Akums Drugs & Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals FAQs
What is Share Price of Akums Drugs & Pharmaceuticals ?
Akums Drugs & Pharmaceuticals share price is ₹855 As on 18 September, 2024 | 02:29
What is the Market Cap of Akums Drugs & Pharmaceuticals ?
The Market Cap of Akums Drugs & Pharmaceuticals is ₹13461.1 Cr As on 18 September, 2024 | 02:29
What is the P/E ratio of Akums Drugs & Pharmaceuticals ?
The P/E ratio of Akums Drugs & Pharmaceuticals is As on 18 September, 2024 | 02:29
What is the PB ratio of Akums Drugs & Pharmaceuticals ?
The PB ratio of Akums Drugs & Pharmaceuticals is 18.7 As on 18 September, 2024 | 02:29